Newsletter
Every new paper in this field, in your inbox.
Surgical oncologists face the challenge of managing gastrointestinal midgut neuroendocrine neoplasms (NENs), particularly neuroendocrine tumors (NETs). While guidelines offer valuable insights, they rely on expert opinions and retrospective evidence. This review outlines recent recommendations for managing midgut NETs, emphasizing the need for individualized approaches based…
Endoscopic resection (ER) has shown to be an effective and safe method for treating gastric gastrointestinal stromal tumors (GISTs), as suggested by a retrospective study in a large tertiary hospital in China. With a sample size of over 300 patients and a follow-up period longer…
This study assessed the utility and costs of surveillance imaging for low- and very low-risk gastrointestinal stromal tumors. The researchers reviewed the surveillance strategy in 60 patients and found that frequent imaging studies were performed with little yield and at substantial cost. No recurrences were…
A systematic review was conducted to assess the presentation, diagnosis, optimal surgical approach, and post-operative outcomes of abdominal catastrophes secondary to intestinal lymphomas. A total of 95 patients were identified, with Burkitt's lymphoma and diffuse large B-cell lymphoma being the most common types. Small bowel…
The study aimed to propose a new surgical classification for non-malignant gastrointestinal mesenchymal tumors (GMTs) based on their location and guide minimally invasive surgical strategies. The classification divided the tumors into two groups (exophytic and transmural/intragastric) and further subdivided them based on location. The study…
Gastric neuroendocrine tumors (G-NETs) are rare tumors originating from the gastric mucosa, classified into three subtypes based on their characteristics and behavior. Type 1 and 2 are typically multifocal and associated with elevated serum gastrin levels. Type 2 causes symptoms like abdominal pain and diarrhea.…
The study investigated the impact of primary tumor resection on the development of disease-specific complications in patients with metastatic well-differentiated small bowel neuroendocrine tumors (SBNETs). The retrospective analysis of 180 patients showed that rates of event-free survival did not differ based on primary tumor management.…
Emerging innovations and advancements in the treatment of extremity and truncal soft tissue sarcomas are explored in this special edition update. The study covers classifications, emerging technologies, prognostic tools, radiation schemas, and treatment disparities. The results emphasize the importance of enhancing local control and reducing…
Small bowel neuroendocrine tumors (SB-NETs) are increasingly identified and have become the most frequent entity among small bowel tumors. Surgical treatment goals include control of tumor volume, endocrine secretion, and prevention of locoregional complications. The study presents eight steps for systematic surgical planning and execution…
In addressing the surge in small bowel neuroendocrine tumors (SB-NETs), this study underscores surgery's pivotal role. Emphasizing multifocal assessment and mesenteric-sparing strategies, it delineates eight systematic steps for surgical planning. While stressing the necessity of achieving oncological control, some controversies persist, notably regarding resection in…
